secwatch.observer — SEC 8-K summary
======================================

Issuer:     FILANA THERAPEUTICS, INC. (FLNA)
CIK:        0001069530
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001069530-22-000051
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cassava Sciences appoints R. Christopher Cook as SVP and General Counsel, effective Dec 1, 2022
--------------------------------------------------------------------------------

- Cook will receive annual base salary of $425,000 and option to purchase 100,000 shares vesting over 48 months.
- He joins from Alcon Inc., where he was Global Head of Litigation and Government Investigations since 2017.
- Previously a litigation partner at Jones Day and an Assistant U.S. Attorney in Chicago.
- This is a newly created position reporting to President & CEO Remi Barbier.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069530/000106953022000051/0001069530-22-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069530/000106953022000051/sava-20221013x8k.htm
  HTML page:      https://secwatch.observer/filing/0001069530-22-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer